Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The Bottom Line is This...... The idea of the direction of the company has major value, the pump was based on a lie (holding some ridiculous number of BTC) If they can pull off their business plan then this WILL be a lot higher PPS-wise. Lastly, if this is only a pump and dump, the pumpers couldn't have made THAT much money. it did go up HUGE on a % basis but unless then got out on the way up, then they are stuck in there at these prices, and they can't unload shares like they would want to.....a.k.a.... this will need more pumping. I see higher prices coming.
Prepare for LIFTOFF! My Price Target before 2014 is $6.50
All good news for $LYG. Pre-market trading is jokes. This thing is going to break $6 by Friday in my opinion.
Oh yea. I have no doubt we will see $6 very soon.
Seeing some nice support at the 5.19 area and now some nice bullish action. Let's see how this plays out. Remember, we get an update in the conference call tomorrow morning.
Moving from a buy to a hold, in my opinion, is not a negative situation. As you can see, the stock has run up quite a bit this year and anyone who is currently invested should hold, is what they are saying but since it ran up so much they are weary to buy at these levels. I personally think it is a great buy at these levels and some news coming out in the next few weeks will send it way over $6 a share.
Actually looking at it more closely they took if from a buy to a hold.
Here is a better link LYG upgrade
Looks like A LOT of share accumulation at 5.22 today.
$LYG is an awesome stock. If you take a look at the monthly chart there is no doubt this thing is gonna BOOM UP! and BREAK OUT! very soon. They are close to closing a partnership deal with Aberdeen and they are having a conference call tomorrow morning Oct. 29th at 9:30 eastern time. I am excited to hear what they have to say! I think this call could send the stock up and over $6. PLUS, they are releasing earning Nov. 7th. There is a lot news in the pipeline for this stock to go well over $10 a share in 2014! Lloyds Banking Group, Long and Strong!
Still holding my shares. The bad news is.....no news at all. The good news is that the share price is so cheap that it's selling at a bargain , IF we happen to get some good news soon. Can't wait for that new game to come out. Hopefully the time and effort they are putting into it will pay off.
Well, they reported revenue on December 31, 2012. So it seems that information is outdated, as you said its over 7 years old.
http://www.otcmarkets.com/stock/FRZT/financials
Not looking bad here either. If anything, the fact that no one is selling off is a pretty neutral to positive indicator. This run started at .0016 so most people that got in early are still in a good position. Nothing is really here to propel any buys at the moment, but with a little news FRZT could end up moving over a .01
SIRI falling, CFO sold more than 90% of his shares! Serious pullback coming!
and how it affects the PPS, of course.
Wow, serious technical breakout if it holds above $655....maybe they won the EKDKQ (Eastman Kodak) Patents auction agains AAPL ;)
Same assessment. Great short from anything over $649
Well, I disagree with you. The chart shows the PPS reaction to every piece of information and it's showing a need for a major pullback. Although the chart is not a flawless trading tool, it is a tool none-the-less, and quite possibly the best we have to make predictions. Remember, it's impossible to predict the future but you will never make money telling people that, "it's impossible to predict the future," unless you are writing a book.
I appreciate your demeanor and I was saying the way this guy was trading and wanting the stock to go up up up is a dream. I think the product is fantastic and in the future the stock will do well but right now it has run up WAY WAY WAY too high and too fast. For that reason it needs to pull back to ATLEAST $2.25 near term.
Any professional trader or investor will tell you that when a stock runs from $1.27 to $2.51 in less than a year (a more than 95% gain) you should AT LEAST take half your position off the table, if not SELL EVERYTHING IMMEDIATELY, as I would. Greed is the quickest way to lose on a winning trade. I've been there.
Just reiterating my short position. Check out the Form 4 filing for August 9th 2012, the day the stock broke out. The CFO of Sirius Satellite Radio sold millions of shares when he had another year to sell them. He sold at $2.48 (just near the high) same day as the "breakout." In my opinion it will fail and move back down to $2.00 before finding support around the 200-Day EMA. Take profits or get short IMO. Next week should be quite interesting.
Ha well since you put it so sweetly, and you are trading on hopes and dreams, I would love to see it fall to about $1.75 and lead all the pigs to slaughter.....:) By the way the CFO.... you know the guy in charge of all the finances in the company, he sold 3 million shares yesterday at 2.48 so obvious he sees a HUGE reason to sell. I would follow his lead..... before it's too late.
Short till $2
There will be better opportunities. I like SIRI short until $2.00 Then I find $2.00 per share very attractive and will be long.
Good Luck
GET SHORT Big pullback coming, daily and weekly charts say so. You have been warned.
Good Luck
SHORT WYNN!!!! SHE'S GONNA BLOW!
IMO ofcourse
BUYERS BEWARE, looks like a triple top has formed. Should be all down hill from here till the $620 - $615 level.
"Arena Pharmaceuticals (ARNA) was down yesterday $0.68 (5.76%) to close at $11.13/share yesterday as 22.8 million shares were traded. The volume was down a bit, but that is to be expected as the news cycle has died down a bit and volatility continues to fall. Based on the price targets we released yesterday we would be buyers of this as shares approach $10/share. We find value there and would use shares purchased around that level to trade around one's core position or simply add to that position. We would not try to get fancy with shorting others hoping to bring diet drugs to market while using the proceeds to go long Arena or shorting Arena to go long those players on the assumption that their drugs get approved as the trade is pretty risky. Simply choose to go either long or neutral these stocks and play them from there, that is our advice this morning to the questions that came in yesterday."
"Healthcare Conference on Thursday, July 12, 2012, at 9 a.m. Eastern Time (6 a.m. Pacific Time)"
SOURCE: http://finance.yahoo.com/news/arena-pharmaceuticals-present-seventh-annual-200500298.html" rel="nofollow" target="_blank" >http://finance.yahoo.com/news/arena-pharmaceuticals-present-seventh-annual-200500298.html
ARTICLE:
SAN DIEGO, July 9, 2012 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA) announced today that the company is scheduled to present at the Seventh Annual JMP Securities Healthcare Conference on Thursday, July 12, 2012, at 9 a.m. Eastern Time (6 a.m. Pacific Time) at The Peninsula New York Hotel in New York City. Craig M. Audet, Arena's Senior Vice President, Operations and Head of Global Regulatory Affairs, is scheduled to provide a corporate overview.
A live audio webcast of the presentation will be available under the investor relations section of Arena's website at www.arenapharm.com. A replay of the presentation will be available for 30 days following the event. Please connect to Arena's website several minutes prior to the start of the webcast to ensure adequate time for any software download that may be necessary.
About Arena Pharmaceuticals
Arena Pharmaceuticals, Inc., is a biopharmaceutical company focused on discovering, developing and commercializing oral drugs that target G protein-coupled receptors, an important class of validated drug targets, in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. For more information about Arena Pharmaceuticals, please visit www.arenapharm.com.
Arena Pharmaceuticals® and Arena® are registered service marks of Arena Pharmaceuticals, Inc.
Forward Looking Statements
Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about Arena's focus, goals, strategy, research and development programs, and ability to develop compounds and commercialize drugs. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, the following: the timing and outcome of DEA, EMA and other regulatory review is uncertain; limitations on the indicated uses, distribution, marketing and other limitations on BELVIQ or, if approved, any of Arena's other drug candidates; risks related to commercializing drugs, including regulatory, manufacturing and supply issues and the pace of market acceptance; cash and revenues generated from BELVIQ, including timing and impact of competition; government and commercial reimbursement and pricing decisions; risks related to relying on collaborative agreements; the timing and receipt of payments and fees, if any, from collaborators; unexpected or unfavorable new data; nonclinical and clinical data is voluminous and detailed, and regulatory agencies may interpret or weigh the importance of data differently and reach different conclusions than Arena or others, request additional information, have additional recommendations or change their guidance or requirements before or after approval; data and other information related to any of Arena's research and development programs may not meet safety, efficacy or other regulatory requirements or otherwise be sufficient for regulatory review, approval or continued marketing; Arena's ability to obtain and defend patents; the timing, success and cost of Arena's research and development programs; results of clinical trials and other studies are subject to different interpretations and may not be predictive of future results; clinical trials and other studies may not proceed at the time or in the manner expected or at all; having adequate funds; and satisfactory resolution of litigation or other disagreements with others. Additional factors that could cause actual results to differ materially from those stated or implied by Arena's forward-looking statements are disclosed in Arena's filings with the Securities and Exchange Commission. These forward-looking statements represent Arena's judgment as of the time of this release. Arena disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.
Don't want to speak too soon but it looks like we found some support around 10.09 10.10 area
Only a matter of time before the sellers dry up and we blast off to $13. Great share prices while we are waiting :)
All I am saying is wait for a day when the dow is up 100 - 200 points and nadaq up a few % this thing will be soaring. AKA TOMORROW!!!
POWER HOUR!!! If they let this run we should be at $12 by EOD. I believe the conference is also tomorrow morning (correct me if I am wrong) which could unleash some good news.
Of course you are, I wasn't doubting that, just making a general statement to all.
***TO ALL THOSE SHORT: BEWARE*** Whomever is/are running ARNA they have UNLIMITED MONEY and they are obviously setting their sights much higher that $11 a share. Get long or get out IMO.
WHAAAAAAAAAAAAAAAAAAAAAAAAAAA: ONE TRADE ON ASK:
PPS: 11.30 # of Shares 100,000 MM: NDD Time: 14:04:25
Ah, okay old timer. Used to be a "day trader" I don't have enough capital for that these days. Just playing it "safe" kind-of haa. Good luck to you as well.
I'm looking purely at a chart, no L2 involved, if that changes something as far as the technicals on the chart, you can explain that to me.
I'm pretty sure I took that into account. Whatever you want to say dude. I don't see where you get $9.95. Please explain your certainty on ANYTHING under $10.50 which still doesn't make sense since the only way the MACD hits 0.0 is if it goes up, which from these levels (low 11's) could only mean that the PPS would be ATLEAST 11.30 - 11.50. Am I missing something?
lol you're nuts bro, it's at -.03 currently trading @ 11.13, it should be trading more like 11.45 when it cracks above 0
BIG BOY shares trading on the ask higher and higher, little baby shares selling off, HA. The same little guys selling off this morning will be chasing the 12's all the way up to the 13's sooner than they think.